The clinical development of the glass-ionomer cement. III. The erosion lesion.
A clinical trial of the glass-ionomer cement, ASPA IV, as a restorative material for erosion lesions is reported. The failure rate, in a three-year trial, was nine per cent; most failures occurring within the first few months after placement.